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Abstract Maternal obesity during pregnancy is an
important public health problem in Western countries.
Currently, obesity prevalence rates in pregnant women are
estimated to be as high as 30 %. In addition, approximately
40 % of women gain an excessive amount of weight during
pregnancy in Western countries. An accumulating body of
evidence suggests a long-term impact of maternal obesity
and excessive weight gain during pregnancy on adiposity,
cardiovascular and metabolic related health outcomes in
the offspring in fetal life, childhood and adulthood. In this
review, we discuss results from recent studies, potential
underlying mechanisms and challenges for future epi-
demiological studies.
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Introduction
Obesity, cardiovascular disease and type 2 diabetes are
major public health problems. These common diseases
have a large impact on morbidity and mortality in the
general adult population [1–4]. Various socio-demographic
and lifestyle-related risk factors for these diseases have
been identified in both childhood and adulthood, of which
many have been published in this journal [5–26]. Also,
adverse exposures during the fetal and early postnatal
period may influence the risk of adverse health outcomes in
later life [27]. Previous epidemiological studies have
shown that both low and high birth weight are associated
with increased risks of obesity, cardiovascular disease and
type 2 diabetes in later life [27–31]. These findings are
supported by experimental animal studies [27, 32]. Thus,
previous research suggests that both restricted and exces-
sive nutritional in utero environments may lead to cardio-
vascular disease in later life.
In Western countries, maternal obesity during pregnancy
is an important adverse risk factor for an excessive nutri-
tional in utero environment [33, 34]. Currently, the obesity
prevalence rate in pregnant women is estimated to be as
high as 30 % [35, 36]. Also, based on the US Institute of
Medicine (IOM) guidelines, approximately 40 % of
women gain an excessive amount of weight during preg-
nancy in Western countries [37]. The IOM guidelines
define optimal ranges of maternal weight gain during
pregnancy according to a mother’s prepregnancy body
mass index, and have been established based on evidence
from observational studies that relate gestational weight
gain to various maternal and offspring outcomes (Table 1)
[37].
As described previously, both maternal prepregnancy
obesity and excessive gestational weight gain seem to have
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persistent effects on various childhood outcomes [38]. This
review update is focused on the associations of maternal
obesity and excessive weight gain during pregnancy with
specifically cardiovascular and metabolic development in
the offspring from fetal life until adulthood. Results from
recent studies, methodological considerations, potential
underlying mechanisms and challenges for future studies
are discussed.
Fetal development
Maternal prepregnancy obesity and excessive weight gain
during pregnancy are important risk factors for a variety of
adverse fetal outcomes (Table 2). A meta-analysis based on
published results from 9 observational studies showed that the
unadjusted odds ratios of a stillbirth were 1.47 (95 % confi-
dence interval (CI) 1.08–1.94) and 2.07 (95 % CI 1.59–2.74)
among overweight and obese pregnant women, respectively,
compared with normal-weight pregnant women [39]. When
this meta-analysis was restricted to studies that performed
adjusted analyses, results did not materially change. In line
with this meta-analysis, a study among 1857,822 live single
births in Sweden showed that a higher maternal body mass
index in early pregnancy was associated with an increased
risk of infant mortality, especially among term births
(C37 weeks) [40]. This association was mainly explained by
congenital anomalies, birth asphyxia, other neonatal mor-
bidities, sudden infant death syndrome or infections [40]. A
meta-analysis among 18 observational studies showed that
maternal obesity was associated with an increased risk of a
number of congenital anomalies, including neural tube
defects, cardiovascular anomalies, cleft palate, hydrocephaly
and limb reduction anomalies [41].
It is well-known that maternal prepregnancy obesity and
excessive gestational weight gain are associated with an
increased risk of large-size-for gestational age at birth [42,
43]. A recent meta-analysis among 13 studies showed that,
as compared to maternal prepregnancy normal weight,
maternal prepregnancy obesity was associated with a
twofold higher risk of delivering a large size for gestational
age infant [42]. Studies using more detailed maternal
weight and fetal growth measurements showed that a
higher maternal prepregnancy body mass index was asso-
ciated with a higher estimated fetal weight from second
trimester onwards, with stronger associations at older
gestational age [44]. Especially higher second and trimester
maternal weight gain seem to be associated with an
increased risk of large size for gestational age at birth [45,
46]. Furthermore, multiple observational studies have
reported that maternal prepregnancy obesity and excessive
gestational weight gain are associated with increased risks
of low Apgar score, neonatal hypoglycemia and referral to
neonatal intensive care unit [47]. Recently, a meta-analysis
Table 1 Institute of medicine criteria for gestational weight gain
Recommended gestational weight gain defined according to the Institute of Medicine Criteria
Prepregnancy body mass index Recommended amount of total gestational weight gain in kg
Underweight (body mass index\18.5 kg/m2) 12.5–18
Normal weight (body mass index C18.5–24.9 kg/m2) 11.5–16
Overweight (body mass index C25.0–29.9 kg/m2) 7–11.5
Obesity (body mass index C30.0 kg/m2) 5–9
Recommended gestational weight gain guidelines according to women’s prepregnancy body mass index. Adapted from the IOM criteria [37]
Table 2 Adverse offspring outcomes of maternal obesity during pregnancy
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of multiple randomized controlled trials showed that diet-
ary and physical activity interventions aimed at reducing
maternal weight gain during pregnancy may lead to small
reductions in the amount of gestational weight gain and to
lower risks of adverse fetal outcomes [48].
Fewer studies assessed the direct influence of maternal
obesity during pregnancy on placental and fetal cardio-
vascular and metabolic development. It has been shown
that maternal prepregnancy obesity is associated with
higher placental weight, placental vascular dysfunction,
placental inflammation and alterations in placental trans-
porters activity and mitochondrial activity [49–55]. A study
among 1035 mother-infant pairs showed that placental
weight partially mediates the effect of maternal prepreg-
nancy obesity and excessive gestational weight gain on
birth weight [49]. Higher maternal prepregnancy body
mass index and gestational weight gain have been associ-
ated with higher leptin and C-peptide levels in cord blood
[56–59]. The associations of maternal body mass index and
weight gain with detailed embryonic and fetal cardiovas-
cular development remain to be studied.
Thus, both maternal prepregnancy obesity and excessive
gestational weight gain lead to increased risks of adverse
fetal outcomes. Overall, maternal prepregnancy obesity
appears to be more strongly associated with adverse fetal
outcomes than excessive maternal gestational weight gain
[45, 47].
Cardiovascular and metabolic development
in childhood
Maternal prepregnancy obesity and excessive gestational
weight gain are associated with an increased risk of obesity
in childhood and adolescence (Table 2). A meta-analysis
among 4 studies showed that maternal prepregnancy obe-
sity was associated with a threefold higher risk of child-
hood obesity [60]. Similarly, a meta-analysis among 12
studies showed that as compared to a recommended
amount of gestational weight gain according to the IOM
criteria, excessive gestational weight gain was associated
with a 33 % increased risk of childhood obesity [61]. The
associations of maternal obesity during pregnancy with
more detailed childhood fat mass measures have also been
studied. Several studies have shown that a higher maternal
prepregnancy body mass index is associated with a higher
childhood waist circumference and total body fat mass
[62–65]. Result from the Generation R Study in Rotterdam,
The Netherlands, have previously shown among 4871
mother-offspring pairs that a higher maternal prepregnancy
body mass index was associated with a higher childhood
total body fat mass, android/gynoid fat mass ratio,
abdominal subcutaneous fat mass and abdominal
preperitoneal fat mass, a measure of visceral fat mass [62].
Higher maternal weight gain during pregnancy is, inde-
pendent from maternal prepregnancy body mass index,
associated with a higher childhood body mass index, but
associations with other fat mass measures are less consis-
tent [65–70]. Also, both maternal prepregnancy obesity and
excessive gestational weight gain seem to be associated
with a higher blood pressure, adverse lipid profile, insulin
resistance and higher inflammatory markers in childhood
[62, 66, 68, 71, 72]. However, these associations are less
consistent than those for childhood adiposity measures and,
if present, seem to be largely mediated by childhood body
mass index. Importantly, the associations of maternal body
mass index and gestational weight gain with childhood
outcomes seem not to be restricted to maternal obesity or
excessive gestational weight gain, but are present across
the full-range of maternal body mass index and gestational
weight gain.
Several studies aimed to identify critical periods of
maternal weight during pregnancy for childhood outcomes.
A study performed among 5154 UK mother-offspring pairs
showed that especially gestational weight gain in the first
14 weeks of pregnancy was positively associated with
offspring adiposity at 9 years of age [68]. In line with these
findings, a study among 5908 Dutch mother-offspring pairs
showed that independent from maternal prepregnancy
weight and weight gain in later pregnancy, early-pregnancy
weight gain was associated with an adverse cardio-meta-
bolic profile in childhood [66]. A study among 977
mother–child pairs from Greece showed that maternal first
trimester weight gain was associated with an increased risk
of childhood obesity and a higher childhood diastolic blood
pressure [46]. A Finnish study among 6637 mothers and
their adolescent offspring showed that maternal weight
gain of[7 kg in the first 20 weeks of gestation was asso-
ciated with the risk of offspring overweight at the age of
16 years [73]. These studies suggest that especially
maternal weight gain in early pregnancy, when maternal fat
accumulation forms a relatively large component of ges-
tational weight gain, may be a critical period for an adverse
childhood cardiovascular risk profile.
Thus, next to the risks of adverse fetal outcomes,
maternal prepregnancy obesity and excessive gestational
weight gain may lead to increased risks of adiposity and
adverse cardiovascular risk factors in childhood and
adolescence.
Cardiovascular and metabolic disease in adulthood
Multiple studies have shown that a higher maternal
prepregnancy body mass index is associated with a higher
adult body mass index in the offspring, independent from
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socio-demographic and lifestyle-related confounding fac-
tors [74–76] (Table 2). Similarly, increased maternal weight
gain during pregnancy has been associated with higher
offspring adiposity levels in adulthood [74, 76–79]. A study
among 2432 Australians showed that higher maternal ges-
tational weight gain was, independent from maternal
prepregnancy body mass index, associated with a higher
body mass index and tended to be associated with a higher
systolic blood pressure in the offspring at the age 21 years
[79]. A study among 1400 mother-offspring pairs in Jer-
usalem showed that higher maternal prepregnancy body
mass index was associated with a higher body mass index,
waist circumference, blood pressures, insulin and triglyc-
eride levels and lower HDL cholesterol in the offspring aged
32 years [74]. Adjustment for adult concurrent body mass
index fully explained the associations of maternal prepreg-
nancy body mass index with cardio-metabolic risk factors in
adulthood. In the same study, higher maternal gestational
weight gain was only associated with increased adiposity
levels in adult offspring [74]. Another study among 308
Danish mother-offspring pairs, which assessed the associa-
tions of maternal weight gain among normal weight women,
showed that a higher maternal weight gain was associated
with higher insulin levels and leptin levels among male
offspring only [77]. Recently, a study using birth records
from 37,709 participants, showed that a higher maternal
body mass index at the first antenatal visit was associated
with an increased risk of premature all-cause mortality and
hospital admissions for cardiovascular events in adult off-
spring [80]. These associations were not explained by
adjustment for maternal age at delivery, socioeconomic
status, sex of offspring, current age, birth weight, gestation
at delivery, and gestation at measurement of body mass
index. In the adjusted model, the hazard of all-cause mor-
tality in offspring of obese mothers was 1.35 (95 % CI
1.17–1.55), as compared to offspring from mothers with a
normal body mass index. In this study, no information on
gestational weight gain or offspring body mass index was
available [80].
Thus, in line with the associations of maternal
prepregnancy obesity and excessive gestational weight
gain with childhood outcomes, these adverse maternal
exposures are associated with an increased risk of adiposity
and cardiovascular and metabolic disease and mortality in
the adult offspring.
Approaches to assess causality for the observed
associations
The major limitation of these observational studies is
confounding. Various family-based socio-demographic,
nutritional, lifestyle related and genetic characteristics may
explain the observed associations of maternal prepreg-
nancy body mass index and gestational weight gain with
adverse health outcomes in the offspring. Few studies used
more sophisticated study designs to obtain further insight
into the role of confounding in the observed associations,
including sibling comparison studies, maternal and paternal
offspring comparisons analyses, Mendelian randomization
studies, and randomized controlled trial analyses, as
described previously [38].
First, sibling comparison studies enable better control
for potential confounding factors shared within families
[81]. A sibling comparison study among offspring from
mothers who had high levels of prepregnancy weight loss
due to gastrointestinal bypass surgery showed that the risk
of overweight and obesity and adverse cardio-metabolic
risk factors was higher in children born to mothers before
surgery than those born to mothers after surgery [82, 83]. A
sibling comparison study among 42,133 women who had
more than one singleton pregnancy and their 91,045 off-
spring showed that higher maternal total gestational weight
gain was associated with a higher body mass index in
childhood [84]. A study using a sibling comparison design
among 280.866 singleton-born Swedish men showed that a
higher maternal body mass index in early pregnancy was
associated with higher offspring body mass index at the age
of 18 years in the whole cohort and between non-siblings,
but not within-siblings, which suggests that the association
may be explained by confounding environmental charac-
teristics [85]. However, among the same study population
it was shown that among overweight and obese mothers,
higher total gestational weight gain was associated with
higher offspring body mass index at the age of 18 years
among siblings, which suggests a possible intra-uterine
effect for gestational weight gain [86]. A limitation of
sibling comparison studies is that next to the major expo-
sure of interest, such as maternal body mass index, other
related characteristics may also change over time.
Second, several studies compared the strength of asso-
ciations of maternal and paternal body mass index with
offspring outcomes as an aid to further disentangle
underlying mechanisms. Stronger associations for maternal
body mass index suggest direct intrauterine mechanisms,
whereas similar or stronger associations for paternal body
mass index suggest a role for shared family-based, life-
style-related characteristics or genetic factors [87]. Studies
comparing associations of maternal and paternal body mass
index with childhood body mass index have shown con-
flicting results [88]. However, studies examining these
associations with more detailed childhood fat mass mea-
sures and other cardio-metabolic risk factors, have shown
that maternal prepregnancy body mass index tends to be
more strongly associated with childhood total fat mass,
android/gynoid fat mass ratio and clustering of cardio-
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metabolic risk factors than paternal body mass index [62–
64]. These findings suggest that some of the effects of
maternal prepregnancy obesity on offspring outcomes may
be through direct intra-uterine mechanisms.
Third, Mendelian randomization approaches use genetic
variants, known to be robustly associated with the exposure
of interest and not affected by confounding, as an instru-
mental variable for a specific exposure [89]. Associations
of these genetic variants with the outcomes of interest
support causality for these associations. A study among
4091 mother-offspring pairs, showed no association of
maternal FTO with childhood fat mass at the age of 9 years
[64]. Thus far, no other Mendelian randomization studies
on these specific associations have been performed.
Fourth, randomized controlled trials are considered as
the golden standard for causality studies. Because ran-
domized studies are difficult to perform when maternal
prepregnancy obesity and excessive gestational weight
gain are the major exposures of interest, previous studies
focused on influencing determinants of obesity and
excessive gestational weight gain, such as dietary factors
and physical activity levels [48]. Based on results from
randomized controlled trials, it has been suggested that
especially dietary interventions during pregnancy may lead
to a small reduction in the amount of gestational weight
gain [48]. However, whether they also have a beneficial
effect on long-term offspring health outcomes remains
unclear. A small randomized controlled trial among 254
mothers and their children, which provided both dietary
advice and exercise to obese women during pregnancy,
observed no difference in body mass index or metabolic
risk factors in the offspring at the age of 2.8 years, when
compared to the control group and an external reference
group of normal weight women [90].
Altogether, results from studies specifically designed to
explore the causality for the associations of maternal obe-
sity during pregnancy with offspring outcomes are not
conclusive yet.
Programming effects of maternal obesity
during pregnancy
Hypothesis
The mechanisms underlying the associations of maternal
obesity or excessive gestational weight gain with cardio-
vascular and metabolic disease in the offspring are not
known yet. The fetal overnutrition hypothesis suggests that
increased placental transfer of nutrients to the developing
fetus in obese mothers and mothers with high levels of
gestational weight gain, may subsequently affect fetal
development, fetal fat deposition and the development of
the hypothalamic-endocrine system that controls appetite
and energy metabolism [91–93]. These adaptations may
predispose individuals to a greater risk of adverse health
outcomes in later life. Figure 1 shows potential mecha-
nisms that might be involved in the associations of higher
maternal prepregnancy body mass index and gestational
weight gain with the risks of cardiovascular and metabolic
disease in the offspring.
Specific maternal exposures
Maternal prepregnancy obesity and excessive gestational
weight gain are complex traits, which reflect multiple
components. Maternal prepregnancy obesity reflects
maternal nutritional status, fat accumulation and low-grade
inflammation, whereas maternal weight gain during preg-
nancy additionally reflects maternal and amniotic fluid
expansion and growth of the fetus, placenta and uterus
[37].
Maternal prepregnancy obesity is an indicator of a poor
quality maternal diet. Both macronutrients and micronu-
trients intake related to a Western diet may influence fetal
cardiovascular and metabolic development, through influ-
ences on placental transfer and subsequently offspring fat
deposition, adipocyte function, pancreatic function and
food preference [91, 94]. A study among 585 mothers and
their children showed that a maternal diet during pregnancy
high in saturated fat and sugar intake was associated with
an increased risk of offspring obesity [95]. Also, several
studies suggested that a low maternal Omega-3 and high
Omega-6 fatty acids intake and plasma levels are associ-
ated with an increased risk of obesity in the offspring [96–
98]. A study among 906 mother–child pairs showed that
higher maternal dietary glycemic index and glycemic load
in early pregnancy, but not later in pregnancy, were asso-
ciated with higher fat mass in childhood [99]. A study
among approximately 3000 mothers, fathers and their
children showed that maternal dietary intake of proteins,
fat and carbohydrates during pregnancy, but not paternal
dietary intake, was associated with the child’s dietary
intake of the same macronutrients. The associations of
maternal dietary intake during pregnancy with child’s
dietary intake were also stronger than the associations of
maternal postnatal dietary intake, which suggest that in
utero mechanisms may play a role in the programming of
offspring appetite [100]. Altogether, these studies suggest
that various measures reflecting a suboptimal dietary status
in pregnant women are associated with adverse cardio-
vascular and metabolic outcomes in offspring.
Maternal prepregnancy obesity and excessive gesta-
tional weight gain partly reflect maternal fat accumulation,
which is important for fetal development [101]. However,
during pregnancy, fat accumulation predominantly occurs
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centrally [101]. Central fat accumulation is associated with
an adverse cardiovascular and metabolic risk profile in
adults, including pregnant women [102]. The metabolic
disturbances may involve dyslipidemia and insulin resis-
tance, which leads to higher maternal circulating levels of
free fatty acids, amino acids and glucose, which affect
placental and fetal development [101]. A small study
among 40 pregnant women showed that maternal insulin
secretory response in early pregnancy, but not before or
later in pregnancy, was associated with increased placental
growth [103]. It has been suggested that excessive maternal
nutrition to the developing fetus, especially hyperglycemia,
may lead to teratogenicity in the first trimester of preg-
nancy [104, 105]. Also, gestational diabetes, glycosuria and
higher maternal fasting glucose levels during pregnancy
are associated with higher weight and c-peptide levels at
birth and body mass index, fat mass level, fasting glucose
and insulin levels in the offspring [106–110]. Two sibling
comparison studies, conducted in the Pima of Arizona and
Sweden, respectively, showed that body mass index and the
risk of type 2 diabetes were higher among offspring from
mothers with diabetes during pregnancy, as compared to
their siblings who were born when the mother did not have
diabetes [85, 111]. Small observational studies have sug-
gested that, independent from maternal prepregnancy body
mass index, higher maternal triglyceride and amino acid
levels are associated with a higher birth weight and
neonatal fat mass [112–115]. Thus, maternal fat distribu-
tion and metabolic profile during pregnancy may have
persistent effects on fetal development and cardio-meta-
bolic development in later life.
Low grade systemic inflammation may be involved in
pathways leading from maternal obesity or excessive ges-
tational weight gain to adverse offspring outcomes. Obesity
is associated with low-grade systemic inflammation and
oxidative stress, also during pregnancy [116–118]. Addi-
tionally, pregnancy itself leads to a state of mild maternal
systemic inflammation, which may interact with obesity-
mediated inflammatory mechanisms [119–122]. It has been
shown that maternal inflammatory markers during preg-
nancy correlate with fetal growth and neonatal fat mass
[123, 124], but the effects at older ages are less clear. A
recent study among 439 Danish mother-offspring pairs,
observed no associations of maternal third trimester CRP,
TNF-a, IL-6, and IL-1b with offspring body mass index,
waist circumference, blood pressure and several metabolic
measures at the age of 20 years [125].
Underlying pathways
Both maternal obesity and excessive gestational weight
gain as well as the correlated nutritional, body fat distri-
bution, metabolic and inflammatory exposures may lead to
programming effects in the offspring through several
pathways.
Epigenetic changes in the offspring are likely to play an
important role in developmental programming [126]. Epi-
genetic mechanisms involve a range of modifications to
DNA and associated proteins that together regulate gene
activity [127]. Environmental influences in early life may
induce epigenetic changes, and thereby affect the risk of
cardiovascular and metabolic disease in later life [127].
Fig. 1 Maternal obesity during pregnancy and offspring developmental adaptations (conceptual model for potential underlying mechanisms for
the associations of maternal obesity during pregnancy with adverse cardiovascular and metabolic health outcomes in offspring)
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Although animals studies provide support for epigenetic
modifications due to maternal obesity or a high fat diet,
only few human studies have explored these associations
[126]. Small studies among pregnant women suggested
epigenetic changes of placental genes induced by maternal
obesity and impaired maternal glucose tolerance [121,
128–130]. Also, a human study among 88 mother–child
pairs suggested that maternal weight gain in early preg-
nancy, but not maternal prepregnancy body mass index or
weight gain in later pregnancy, might be associated with
epigenetic modifications in offspring cord blood [131].
Epigenetic modifications as well as other mechanisms may
be involved in adiposity, cardiovascular and metabolic
developmental adaptations.
Offspring from mothers with prepregnancy obesity or
excessive gestational weight gain during pregnancy have
higher fetal growth rates and are at increased risk of being
born large for their gestational age. Higher birth weight is
associated with an increased risk of obesity in later life
[132]. The associations of maternal obesity during preg-
nancy with the risk of obesity in childhood and adulthood
may thus be explained by tracking of body size and fatness
throughout the life course. However, many observational
studies have shown that additional adjustment for birth
weight does not explain the observed associations [38].
This might be explained by birth weight not accurately
reflecting neonatal fat mass, but might also suggest that
other mechanisms play an important role [91]. Animal
studies have suggested that altered adipocyte development
may influence the development of obesity and insulin
resistance in the offspring, as maternal obesity during
pregnancy may affect both offspring adipocyte morphology
and metabolism [92]. Next to altered growth and adipocyte
function, altered appetite control may be a key factor in
developmental programming of obesity. A maternal
hypercalorific diet during pregnancy and overfeeding in the
fetal and early postnatal period is associated with adverse
programming of the hypothalamus, which may lead to
hyperphagia and altered satiety mechanisms [91, 133].
High leptin and insulin levels in the fetal and early post-
natal period are thought to play a central role in this
adverse hypothalamic programming [91].
The associations of maternal prepregnancy body mass
index and gestational weight gain with adverse cardiovas-
cular and metabolic outcomes in the offspring appear to be
largely mediated through offspring obesity. However,
direct cardiovascular and metabolic programming effects
of maternal obesity during pregnancy may also be present
[92]. Animal studies have shown maternal programming
effects on cardiovascular and metabolic outcomes. Mater-
nal obesity and high fat diet during pregnancy are associ-
ated with high blood pressure, endothelial dysfunction,
increased aortic stiffness and cardiac hypertrophy in
rodents [92, 134]. It has been shown that high blood
pressure in offspring occurs, due to selective leptin resis-
tance which increased sympathetic nervous system activity,
before the development of increased adiposity levels and
hyperleptinaemea, which suggests that the selective leptin
resistance was not obesity related but a direct consequence
of the exposure to maternal obesity in early life [134].
Increased maternal glucose transport to the developing
fetus leads to a higher exposure of glucose for the devel-
oping fetal pancreas, which results in acceleration of fetal
pancreatic development [92, 133]. This accelerated pan-
creatic maturation may predispose to premature loss of ß-
cells and consequently lead to impaired glucose and insulin
homoeostatis [133]. Offspring of female rats and mice fed a
high-fat diet during pregnancy have increased triglyceride
levels and oxidative stress in the liver, which may predis-
pose to the development of non-alcohol fatty liver disease,
the hepatic manifestation of the metabolic syndrome [92].
Thus, multiple mechanisms may be involved in the
intra-uterine pathways leading from maternal obesity and
excessive weight gain during pregnancy to long-term
adverse offspring health outcomes.
Perspectives for future epidemiological research
Current evidence from epidemiological studies suggests
that maternal obesity and excessive weight gain during
pregnancy have important adverse consequences on car-
diovascular and metabolic development from fetal life
onwards, leading to disease in later life. Yet, there remain
important issues to be addressed. These include identifi-
cation of the extent of causality of the observed associa-
tions, the underlying exposures and their critical periods,
the developmental adaptations, and the potential for
development of preventive strategies (Table 3).
First, despite extensive adjustment for potential con-
founding factors in these observational studies, residual
confounding may still be an issue. The causality of the
observed associations needs to be further addressed. Large
observational studies that are able to apply more sophisti-
cated methods, such as parent-offspring comparison stud-
ies, sibling comparison studies and Mendelian
randomization-studies are needed to obtain further insight
into the causality of the associations of interest. Long-term
follow-up of participants in trials focused on reducing
maternal weight throughout pregnancy will also provide
further insight into the causality. Large meta-analyses are
needed to obtain further insight into the strength, consis-
tency and independency of the associations.
Second, the underlying mechanisms of the observed
associations of maternal obesity during pregnancy with
offspring health outcomes remain unclear. Animals studies
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have identified multiple pathways that may be involved in
these associations, but these pathways remain largely
unexplored in humans. Maternal prepregnancy obesity and
excessive gestational weight gain are complex traits, which
reflect multiple lifestyle-related and biological components,
which complicates identification of potential underlying
pathways. Future studies may benefit from detailed
assessments of the studied exposures and outcomes
throughout the life-course, which could provide further
insight into potential underlying mechanisms. Studies with
repeated maternal weight measurements during pregnancy
available can identify critical periods of maternal weight
gain. To obtain further insight into the different components
associated with offspring outcomes, studies are needed with
more detailed measurements of maternal nutritional status,
body composition, metabolic and inflammatory measures,
pregnancy-related hemodynamic adaptations and fetal
growth. For the offspring outcomes, more detailed mea-
surements of growth, body composition and cardio-meta-
bolic factors, including cardiac structures, endothelial
function, pulse wave velocity, lipid spectrums and glucose
responses, might also lead to further insight into the
underlying growth, vascular and metabolic mechanisms
present in the observed associations. Since early pregnancy
appears to be a critical period for offspring outcomes,
studies are needed with detailed maternal measurements
from early pregnancy onwards to already assess their
influence on placental and embryonic growth and devel-
opment. Long-term follow up of participants in observa-
tional studies is needed to assess the influence on the risk of
obesity and related cardio-metabolic disorders throughout
the life-course. In addition, it is of interest to conduct fol-
low-up studies of the third generation offspring from these
large observational studies, as this may provide further
insight into the intergenerational effects of maternal obesity
during pregnancy on especially female offspring.
Third, further research is needed focused on prevention
of adverse health outcomes in offspring through optimizing
maternal prepregnancy body mass index, weight gain and
diet during pregnancy. Studies are needed to assess the
optimal amounts of maternal weight gain for short-term
and long-term maternal and offspring health outcomes to
further improve the IOM recommendations for gestational
weight gain. Identification of specific maternal dietary
components associated with offspring health outcomes is
needed to improve maternal dietary recommendations
during pregnancy. Long term follow up of mothers and
their children participating in randomized trials focused on
improving maternal diet and reducing maternal weight
throughout pregnancy will provide insight into the effec-
tiveness of these maternal lifestyle interventions during
pregnancy for improving long-term health of offspring.
Conclusions
Maternal prepregnancy obesity and excessive weight gain
during pregnancy seem to be important risk factors for an
adverse in utero environment and long-term adverse car-
diovascular and metabolic outcomes in the offspring. Well-
designed epidemiological studies are needed to identify the
extent of causality of the observed associations, the
underlying exposures and their critical periods, the devel-
opmental adaptations, and the potential for development of
preventive strategies to improve long-term health outcomes
of offspring.
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